| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |